Prohibited list comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-02-26. Numbers and descriptions here follow the published literature rather than marketing material.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human therapeutic use | No marketing authorization identified in major jurisdictions. |
| Anti-doping class | PPARδ agonist; hormone and metabolic modulators | Listed on the WADA Prohibited List. |
| Common test matrix | Urine | Also blood and tissue in research settings. |
| Typical analytical method | LC-MS/MS | Targets parent compound and metabolites. |
| Major safety signal | Tumor findings in rodents | Human relevance not established; limited human data. |
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
=== Endocrine disruption === LeBlanc's research in the field of toxicology, particularly centered on endocrine disruption, has contributed to the understanding of the impact of environmental contaminants on human and wildlife health. He investigated the impacts of endocrine-disrupting chemicals on mammals, fishes, reptiles, and invertebrates. He identified the suite of nuclear receptors in the crustacean, Daphnia pulex, and functionally characterized several of these receptors. He deciphered the neuro-endocrine signaling pathway responsible for sex determination in some crustaceans, including the discovery of the hormone responsible for sex determination, methyl farnesoate, and its receptor protein. He also demonstrated that some insecticides can mimic the action of methyl farnesoate in daphnids resulting in altered sex ratios of offspring. In 2005, LeBlanc created a mathematical model that integrated concentration addition, response addition, and toxicokinetic interactions to enable the assessment of the toxicity of chemical mixtures. He demonstrated the utility of this model by assessing the joint toxicity of 9 chemicals commonly found in surface waters in the US. This model has been used by regulatory agencies and has been recommended by the National Research Council in the assessment of risks to endangered and threatened species from exposure to pesticide mixtures.
In 2010, Moe's signed a deal to open 40 of its restaurants in Turkey, the first of which opened in 2011. In September 2012, Moe's opened its first Russian franchise located in the center of Moscow near the Kremlin on Pyatnitskaya Street. Franchise partners also existed in Costa Rica and Jamaica.
By the 1970s, chemotaxonomic surveys were uncovering dozens of chemically defined species, underscoring the extent of cryptic diversity. One review reported 240 distinct chemical variants across 99 examined morphospecies. Subsequent DNA studies confirmed that many variants correspond to distinct lineages. Two chemical forms of the long-recognized Parmeliopsis ambigua illustrate this pattern. One form contains usnic acid, the other atranorin. These proved to be separate species when molecular data showed they are not sister taxa. Chemical characters remain central to routine identification and increasingly inform conservation assessments. A 2024 herbarium study of the rare Brodoa oroarctica uncovered misidentified records; only classic spot tests (K, C, Pd) and TLC clarified the species' true range, demonstrating the ongoing value of traditional chemical tools beside modern molecular methods.
Sources: en.wikipedia.org
It is home to the headquarters of three Fortune Global 500 companies, the highest in the region. The nation's best known global companies include Singapore Airlines, Changi Airport, and the Port of Singapore, all of which are among the most-awarded in their respective fields. Singapore Airlines was ranked as Asia's most-admired company, and the world's 19th most-admired company in 2015 by Fortune's annual "50 most admired companies in the world" industry surveys. Other awards it has received include the US-based Travel + Leisure's Best International Airline award, which it has won for 20 consecutive years. Changi Airport connects over 100 airlines to more than 300 cities. The strategic international air hub has more than 480 World's Best Airport awards as of 2015, and is known as the most-awarded airport in the world. Over ten free-trade agreements have been signed with other countries and regions. Singapore is the second-largest foreign investor in India. It is the 14th largest exporter and the 15th largest importer in the world.
Primary hypertrophic osteoarthropathy is HPOA without signs of pulmonary disease. This form has a hereditary component, although subtle cardiac abnormalities can occasionally be found. It is known eponymously as the Touraine–Solente–Golé syndrome. This condition has been linked to mutations in the gene on the fourth chromosome (4q33-q34) coding for the enzyme 15-hydroxyprostaglandin dehydrogenase (HPGD); this leads to decreased breakdown of prostaglandin E2 and elevated levels of this substance. Another congenital form involves mutations in SLCO2A1, which cells use to uptake prostaglandin from the surroundings.
=== Synopsis === Classical pharmacological studies on animals and isolated animal tissues showed that the principal actions of parenterally administered synephrine included raising blood-pressure, dilating the pupil, and constricting peripheral blood vessels. There is now ample evidence(what evidence?) that synephrine produces most of its biological effects by acting as an agonist (i.e. stimulating) at adrenergic receptors, with a distinct preference for the α1 over the α2 sub-type. However, the potency of synephrine at these receptors is relatively low (i.e. relatively large concentrations of the drug are required to activate them). The potency of synephrine at adrenergic receptors of the β-class (regardless of sub-type) is much lower than at α-receptors. There is some evidence that synephrine also has weak activity at 5-HT receptors, and that it interacts with TAAR1 (trace amine-associated receptor 1). In common with virtually all other simple phenylethanolamines (β-hydroxy-phenethylamines), the (R)-(−)-, or l-, enantiomer of synephrine is more potent than the (S)-(+)-, or d-, enantiomer in most, but not all preparations studied. However, the majority of studies have been conducted with a racemic mixture of the two enantiomers.
== Resurgence of Freemasonry in Cuba == In 1855, mainland Spain saw the triumph of the Spanish Revolution of 1854 and the Progressive Biennium. The Cuban oligarchy at the time was highly connected with the reformists of the Liberal Union, especially the former Governor of Cuba, Leopoldo O'Donnell had led the revolution. Reformist ideas were implemented in Cuba in 1857; the freedom of speech, freedom of the press, and the freedom of assembly. With that newfound political freedom, Freemasonry was allowed to reform in Cuba.
Sources: en.wikipedia.org
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.
It is classified as a PPARδ agonist on the WADA Prohibited List. Anti-doping laboratories can detect it and its metabolites in urine. Its use is banned in competition and usually out of competition.
Rodent studies reported increased tumor incidence at multiple sites. The human relevance remains uncertain, but the findings contributed to discontinuation of development. No long-term human cancer data are available.
Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.